Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Binh Tran

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Research Square|December 11, 2025
Predictors of Metabolic Dysfunction-Associated Steatotic Liver Diseases (MALSD) in Vietnamese PopulationAnh Gia Pham, An Vu-Khanh Le, Yen Thi-Hai Pham, et al.
Scientific Reports|April 17, 2026
Predictors of metabolic dysfunction-associated steatotic liver diseases (MASLD) in Vietnamese populationAnh Gia Pham, An Vu-Khanh Le, Yen Thi-Hai Pham, et al.
The Journal of Allergy and Clinical Immunology|December 23, 2018
Effects of diet on the childhood gut microbiome and its implications for atopic dermatitisMahboobeh Mahdavinia, Heather E Rasmussen, Maresa Botha, et al.
Nature|September 1, 2016
Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transitionMarco Sciacovelli, Emanuel Gonçalves, Timothy Isaac Johnson, et al.
Medical Mycology|February 13, 2016
Antifungal susceptibility of invasive Candida bloodstream isolates from the Asia-Pacific regionThean Yen Tan, Li Yang Hsu, Marissa M Alejandria, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 18, 2025
Translation and cultural adaptation of tools to assess diverse Asian American and Asian Canadian subgroups: The Asian Cohort for Alzheimer's Disease (ACAD) StudyHaeok Lee, Marian Tzuang, Tiffany W Chow, et al.
Nature|November 4, 2016
Corrigendum: Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transitionMarco Sciacovelli, Emanuel Gonçalves, Timothy Isaac Johnson, et al.
Cancer|October 13, 2021
Metagenomics and chemotherapy-induced nausea: A roadmap for future researchSylvia L Crowder, Aasha I Hoogland, Taylor L Welniak, et al.
Diagnostic and Prognostic Research|September 12, 2023
Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control studyJane I Grove, Camilla Stephens, M Isabel Lucena, et al.
Ebiomedicine|March 25, 2026
Usefulness of plasma bile acid profile as a prognostic biomarker for drug-induced liver injuryMaria J Monte, Thi Dong-Binh Tran, Jane I Grove, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Research Square|December 11, 2025
Predictors of Metabolic Dysfunction-Associated Steatotic Liver Diseases (MALSD) in Vietnamese PopulationAnh Gia Pham, An Vu-Khanh Le, Yen Thi-Hai Pham, et al.
Scientific Reports|April 17, 2026
Predictors of metabolic dysfunction-associated steatotic liver diseases (MASLD) in Vietnamese populationAnh Gia Pham, An Vu-Khanh Le, Yen Thi-Hai Pham, et al.
The Journal of Allergy and Clinical Immunology|December 23, 2018
Effects of diet on the childhood gut microbiome and its implications for atopic dermatitisMahboobeh Mahdavinia, Heather E Rasmussen, Maresa Botha, et al.
Nature|September 1, 2016
Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transitionMarco Sciacovelli, Emanuel Gonçalves, Timothy Isaac Johnson, et al.
Medical Mycology|February 13, 2016
Antifungal susceptibility of invasive Candida bloodstream isolates from the Asia-Pacific regionThean Yen Tan, Li Yang Hsu, Marissa M Alejandria, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 18, 2025
Translation and cultural adaptation of tools to assess diverse Asian American and Asian Canadian subgroups: The Asian Cohort for Alzheimer's Disease (ACAD) StudyHaeok Lee, Marian Tzuang, Tiffany W Chow, et al.
Nature|November 4, 2016
Corrigendum: Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transitionMarco Sciacovelli, Emanuel Gonçalves, Timothy Isaac Johnson, et al.
Cancer|October 13, 2021
Metagenomics and chemotherapy-induced nausea: A roadmap for future researchSylvia L Crowder, Aasha I Hoogland, Taylor L Welniak, et al.
Diagnostic and Prognostic Research|September 12, 2023
Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control studyJane I Grove, Camilla Stephens, M Isabel Lucena, et al.
Ebiomedicine|March 25, 2026
Usefulness of plasma bile acid profile as a prognostic biomarker for drug-induced liver injuryMaria J Monte, Thi Dong-Binh Tran, Jane I Grove, et al.
Pageof 10